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ABSTRACT Chaen et al. (1986. J. Biol. Chem. 261:13632-13636) showed that treatment of relaxed single muscle fibers with
para-phenylenedimaleimide (pPDM) results in inhibition of a fiber's ability to generate active force and a diminished ATPase
activity. They postulated that the inhibition of force production was due to pPDM's ability to prevent crossbridges from participating
in the normal ATP hydrolysis cycle. We find that the crossbridges produced by pPDM treatment of relaxed muscle cannot bind
strongly to the actin filaments in rigor, but do bind weakly to the actin filaments in the presence and also absence of ATP. After
pPDM treatment, fiber stiffness, as measured using ramp stretches of varying duration, is ATP-insensitive and identical to that of
untreated relaxed fibers (both at high [165 mM] and low [40 mM] ionic strength). These results suggest that the pPDM-treated
crossbridges, in both the presence and absence of ATP, are locked in a state that resembles the weakly-binding myosin ATP
state of normal crossbridges. Their resemblance to the ATP-crossbridges of relaxed untreated fibers is quite strong; both bind to
actin about equally tightly and have similar attachment and detachment rate constants. We also found that crossbridges are locked
in a weakly-binding state after treatment with N-phenylmaleimide (NPM). In muscle fibers, this method of producing weakly-binding
crossbridges appears preferable to pPDM treatment because, unlike treatment with pPDM, it does not increase the fiber's resting
tension and stiffness and it does not disrupt the titin band seen on SDS-PAGE.
INTRODUCTION
Vertebrate skeletal muscle contains a complex architec-
ture of interacting proteins. In muscle fibers, "thin"
actin filaments interdigitate with "thick" bipolar myosin
filaments in a double hexagonal lattice. Actin and
myosin, the primary muscle proteins, interact in a
cyclical fashion to produce physical work and force,
presumably via conformational changes coupled to the
energy derived from actin-activated adenosine-5'-
triphosphate (ATP) hydrolysis by myosin. In pioneering
work, Chaen et al. (1986) showed that treatment of
fibers with the bifunctional alkylating agent, N,N'-1,4-
phenylenedimaleimide (pPDM), results in inhibition of
their ability to produce force. Although there is little
other fiber work concerning the effect of pPDM, there is
a considerable body of knowledge from solution studies
about the effects and mechanism of action of pPDM on
myosin.
Myosin, the major protein constituent of the thick
filament, has a long (- 140 nm) double-stranded alpha-
helical "tail" and two globular "head" regions. Each of
the myosin heads contains actin and nucleotide binding
sites. Near the COOH-terminal region of each head
there are two highly-reactive sulfhydryl groups desig-
nated SH1 and SH2. Modification of either of these
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groups individually with an alkylating reagent inhibits
myosin's ATPase activity in the absence of divalent
cations (Seidel, 1969), while modification of SH1 alone
simultaneously stimulates the ATPase activity in the
presence of divalent cations (Sekine and Kielley, 1964;
Burke et al., 1973). Blockage of both SH groups abol-
ishes all myosin ATPase activity (Sekine and Kielley,
1964; Yamaguchi and Sekine, 1966). While there is
another class of SH groups located in the region of the
myosin head-tail junction that react with alkylating
agents at elevated pH (without change of ATPase
activity), most of the myosin molecule's 42 cysteine
residues are inaccessible to SH-reactive reagents except
under conditions that lead to denaturation of the pro-
tein (Schaub et al., 1975; Schaub et al., 1979).
Alkylation of purified myosin with pPDM in solution
crosslinks the SH1 and SH2 sulfhydryls (Reisler et al.,
1974), resulting in a myosin that binds to actin in the
absence of ATP as weakly as it does in the presence of
ATP and as weakly as untreated myosin binds in the
presence of ATP (Muhlrad et al., 1976). This finding has
been interpreted as suggesting that the crosslinking
mechanically locks the myosin in a configuration resem-
bling that of the weakly-binding M * ATP state (Wells et
al., 1979; Wells et al., 1980). In a parallel fashion, we find
that pPDM treatment of muscle fibers results in creation
of crossbridges locked in a state functionally similar to
the weakly-binding myosin * ATP crossbridge state of
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normal relaxed fibers. In addition, we find that the
monofunctional alkylating agent N-phenylmaleimide
(NPM) similarly produces M - ATP crossbridges in fi-
bers. Our results fit well those of Chaen et al. (1986) who
found that treatment with pPDM inhibits an active
muscle fiber's stiffness and ability to produce force.
ment of the force response. The ionic strength for the step stretch
experiments was 165 mM. In experiments where chord stiffness
(Schoenberg, 1985) was measured, a stretch amplitude of 2 nm/half-
sarcomere was used and the chord stiffness for nine different durations
of the stretch ranging from 10-4 to 1 s was measured. The ionic
strength for the chord stiffness experiments was 40 mM.
METHODS
Treatment of the muscle fibers
Single skinned rabbit psoas fibers were mounted between a modified
Akers 801 force transducer (Sensonor; Horten, Norway) and a
displacement driver as described previously (Schoenberg, 1988a). The
fibers were treated with alkylating agent in either 165 mM ionic
strength relaxing or rigor solution (Table 1). Stock solutions of 30 mM
pPDM or NPM (Aldrich; Milwaukee, WI) in dimethylformamide
(stored at -200C for periods of up to 1 mo) were added to the 2-ml
fiber bath in the correct amount to make the final concentration of
alkylating reagent 200 ,uM for pPDM or 100 FM for NPM. After
thorough mixing, the fiber was incubated without stirring for the
desired treatment period. To quench the alkylating reaction at the end
of the treatment period, the fiber was rinsed thoroughly in a solution
similar to the incubating one except that alkylating reagent was
replaced with 0.5 mM dithiothreitol (DTT). Because this procedure
involved adding a small amount of dimethylformamide, it was shown in
control experiments that adding comparable amounts of dimethylfor-
mamide without alkylating reagent had no effect (data not shown).
Measuring the time course of pPDM
and NPM treatment
In determining the time course of the pPDM- or NPM-induced
changes in muscle fiber stiffness, the relaxed and rigor stiffnesses of the
untreated fibers were first measured as a control. The fiber was then
incubated with alkylating reagent for a specified period of time. At the
end of the treatment period, the reaction was quenched with DTIT and
the relaxed and rigor stiffness again measured. This sequence was
repeated several times consecutively until the accumulated exposure
time to alkylating agent was 60 min. Treatment of a relaxed fiber for 60
min with pPDM or NPM reduces its rigor stiffness to the level of the
relaxed stiffness (see Results). Therefore, in experiments where it was
desirable that all the crossbridges be reacted, the fibers were incubated
with alkylating reagent for 60 min.
Mechanical characterization of the
fibers
In measuring the response to step stretches, the fibers were stretched
- 2 nm/half-sarcomere in 0.4 ms and then held isometric for measure-
TABLE 1 Millimolar concentrations of solution constituents
Solution KCl EGTA MgCl2 MgATP Imidazole
165 mM relaxing 125 4 1 4 10
165 mM rigor 136 4 4 10
40 mM relaxing 4 1 4 10
40 mM rigor 11 4 4 10
All solutions were pH 7.0 + 0.1 at 5°C and contained 0.5 mM DTT.
Solution name gives total ionic strength.
Preparation of gel samples
For gel studies, small muscle bundles 1-2 mm in diameter and 1 cm in
length were attached with a small amount of cyanoacrylic glue between
two fixed stainless steel posts. The length-fixed bundles were then
incubated for 1 h in 0°C relaxing buffer containing either 200 p.M
pPDM or 100 ,uM NPM. After the appropriate incubation period,
treatment of the fibers was terminated by bathing the fibers in relaxing
solution containing 0.5 mM DTT. SDS-PAGE was done using a
protocol based on that of Somerville and Wang (1981). The fiber
bundles were transferred into 200 ,ul of cold (- 4°C) homogenization
buffer and then homogenized in an ice-cold ground glass homogenizer.
The homogenization buffer contained 2 mM EDTA, and 20 mM
tris-(hydroxy-methyl)-aminomethane (Tris), pH 8. Protein concentra-
tions of the homogenates were determined using the Lowry assay and
the final concentration adjusted to 2 mg/ml. To denature the proteins
before application to the gel, theywere mixed 1:1 with 2x electrophore-
sis sample buffer (140 mM 3-mercaptoethanol, 2 mM EDTA, 2%
(vol/vol) SDS, 20% (vol/vol) glycerol, 0.02% (wt/vol) bromphenol
blue, 20 mM Tris, pH 8) and then heated for 2 min in a boiling water
bath.
SDS-PAGE
10-40 p.g samples of homogenized fibers were applied via a Hamilton
syringe to a 2-12% continuous linear gradient polyacrylamide (Fair-
banks et al., 1971) gel as modified by Somerville and Wang (1981). The
gels were run in a Hoeffer SE600 chamber (Hoeffer Scientific, San
Francisco, CA) at 250 V for approximately 2.5 h. Upper and lower
running buffers were identical and contained 20 mM NaAcetate, 2 mM
EDTA, 0.1% (vol/vol) SDS, 40mM Tris pH 7.4. The gels were stained
either for 1 h or overnight while gently shaking in a solution of 0.063%
(wt/vol) Coomassie Blue R-250 (Bio-Rad, Richmond, CA), 10%
acetic acid, and 50% methanol. They were destained with a 1 h soak in
10% acetic acid/50% methanol, followed by 3-4 one hour soaks in
7.5% acetic acid/15% methanol.
Site of pPDM and NPM binding
In order to determine the site ofpPDM and NPM binding, fibers were
treated as described except '4C-pPDM (a gift of Dr. Lois Greene of
NHLBI) or 14C-NPM (Synthesized by Amersham Corp., Arlington
Heights, IL) was used. The dried gels were scanned for 14C using an
AMBIS Radioanalytic Imaging System (AMBIS Systems Inc., San
Diego, CA). The location of radioactivity was compared with the
known migration of the muscle proteins on SDS-PA gels.
Western blotting
Western blots of SDS-PA gels were performed by transferring the
proteins to PVDF paper using a current of 1.0 A for 3.5 h. The transfer
buffer contained 2.5 mM Tris, 19.2 mM glycine, 0.1% SDS, 20%
(vol/vol) methanol, pH 7.5. After the transfer, the nitrocellulose paper
was incubated overnight, at 40C, in a solution of 150 mM NaCl, 0.5%
bovine serum albumin, and 20 mM Tris, pH 7.5. After overnight
incubation, anti-myosin IgG was added to the solution and the
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nitrocellulose paper was allowed to equilibrate for 2 h at room
temperature. After reaction with the anti-myosin IgG, the nitrocellu-
lose filter was thoroughly washed and then incubated for 30 min at
room temperature with mouse anti-rabbit IgG conjugated to alkaline
phosphatase (Promega Inc., Madison, WI). The myosin present was
visualized using the alkaline phosphatase to catalyze a color producing
reaction involving nitro blue tetrazolium (NBT) and 5-bromo-4-chloro-
3-indolyl-phosphate (BCIP). The anti-myosin IgG (donated by Drs. J.
Sellers and Trudy Cornwell of NHLBI) was made from serum of
rabbits innoculated with bovine tracheal muscle myosin and showed
good reactivity to rabbit skeletal muscle myosin.
RESULTS
Treatment of relaxed fibers with
pPDM
When purified myosin subfragment-1 (Si) is labeled
with pPDM in the presence of nucleotide, the fast
reacting sulfhydryls, SH1 and SH2, are crosslinked to
one another (Reisler et al., 1974). This covalent modifi-
cation results in a reduction in myosin's affinity for actin
in the absence ofATP to the level of untreated myosin in
the presence of ATP (Muhlrad et al., 1976; Greene et
al., 1986; Katoh and Morita, 1984; Katoh and Morita,
1984). In fibers, treatment with pPDM under relaxing
conditions results in a decrease of the stiffness of the
fibers during activation (Chaen et al., 1986). In light of
the biochemical results, it seems quite possible that the
reduction in stiffness of activated fibers may be due to
pPDM's ability to crosslink SH1 and SH2 and reduce the
affinity of myosin for actin. If this is the case, treatment
of a relaxed fiber with pPDM should decrease a fiber's
rigor stiffness as well.
In order to examine the changes in rigor stiffness that
accompany pPDM treatment of a resting (p, = 165 mM)
skinned rabbit psoas fiber, we measured the resting and
rigor stiffness after incremental exposures of fibers to
200 ,uM pPDM. The total exposure time was 1 h.
Fig. 1 A shows the time course of the change of both the
resting and rigor stiffness with increasing duration of
pPDM-treatment in relaxing solution. To be certain that
the incremental nature of the exposure was not affecting
the results, we also exposed several fibers to 60 min of
continuous pPDM treatment. Those fibers were found
to be identical to ones treated intermittently for 60 min
(data not shown). As the length of the exposure of the
muscle fiber to pPDM increases, there is a large de-
crease in the rigor stiffness and also a gradual small
increase in the resting stiffness. As discussed above, the
decrease in rigor stiffness with increased exposure to
pPDM is consistent with the observations of Chaen et al.
(1986) on the stiffness of activated fibers.
Treatment of rigor fibers with pPDM
In solution, the rigor attachment of Si to actin decreases
the rate of pPDM crosslinking of myosin's essential
sulfhydryls to less than 1/20th the rate in the absence of
actin (Katoh and Morita, 1984). Thus, if crossbridges are
in rigor when treated with pPDM this should inhibit the
ability of pPDM to reduce rigor stiffness. As Fig. 1 B
shows, this is indeed the case. However two unexpected
results also are seen. When pPDM is used to treat
skinned rabbit psoas fibers in rigor, the rigor stiffness
increases early on to -119% of control value (and
therefore remains relatively constant as incubation time
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FIGURE I Time course of N,N'-para-phenylene dimaleimide (pPDM) treatment of skinned rabbit psoas fibers. pPDM concentration = 200 ,uM;
temperature, 5°C. (A) Treatment in relaxing solution. As the cumulative time ofpPDM exposure increases, the rigor stiffness decreases to the level
of the resting stiffness. The resting stiffness shows an - 5% increase over the 60-min treatment period. Rigor stiffness after pPDM treatment while
relaxed (l). Relaxed stiffness after pPDM treatment while relaxed (0). (B) Treatment in rigor solution. In contrast to the results for treatment of
relaxed fibers, rigor protects against pPDM-induced loss of rigor stiffness. There is, however, an unexplained increase in the resting stiffness. Rigor
stiffness after pPDM treatment while in rigor (O). Relaxed stiffness after pPDM treatment while in rigor (0). Data points are average values; the
error bars show +SEM; the total number of experiments is 14 for relaxed fiber treatment (n = 3 - 6/point) and 6 for rigor fiber treatment
(n = 2 - 6/point). When n = 2, the error bar gives the range.
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is extended out even to 60 min). Another change that
occurs with pPDM treatment of rigor fibers is that the
resting stiffness shows an approximately linear increase
with increasing duration of treatment, reaching as high
as 20% after 60 min incubation. The fact that the
increase in rigor stiffness occurs quickly and then re-
mains relatively constant, while the increase in resting
stiffness occurs more gradually, suggests that these
changes are likely the result of separate labeling events.
Mechanical properties of
pPDM-treated fibers
Step stretch measurements at 165 mM ionic
strength
Fig. 2 shows the mechanical response of a fiber treated
with 200 ,uM pPDM in relaxing solution for 60 min.
After the treatment, 2 nm/half-sarcomere step stretches
were applied to the fiber in both 165 mM ionic strength
rigor and relaxing solutions. As seen from Fig. 1, this
amount of treatment totally eliminates the additional
crossbridge stiffness induced by rigor. Fig. 2 shows that
after 60 min of pPDM treatment the stretch response of
the fiber in both rigor and relaxing solution is largely
indistinguishable from the stretch response of a normal
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relaxed fiber. The characteristic large response of a
normal fiber to stretch in rigor solution is gone in the
treated fiber.
Chord stiffness-duration of stretch
relationship at 40 mM ionic strength
Although at 165 mM ionic strength the stiffness of the
fiber treated for 60 min in relaxing solution with pPDM
is too small to easily study quantitatively, by lowering
ionic strength to 40 mM, it was hoped that the strength
of binding of the pPDM-treated crossbridges might
increase enough to allow an examination of their kinet-
ics. Using a procedure similar to that in Schoenberg
(1988a) the chord stiffness-duration of stretch (SC-log td)
relationship was measured at an ionic strength of 40
mM. As seen in Fig. 3, the chord stiffness-duration of
stretch relationship for the modified fiber in either
relaxing or rigor solutions, is the same as that of a
control relaxed fiber at the same ionic strength. Because
the shape and amplitude of the chord stiffness-log
duration of stretch relationship is determined by the
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FIGURE 2 Original records of response to stretch in 165 mM rigor
and relaxing solution, before and after pPDN4-treatment of a resting
fiber. Incubation time was 60 min. The untreated fiber shows a
substantial resistance to stretch in rigor. When relaxed it no longer
resists the stretch. After pPDM-treatment, the fiber is unable to resist
the step length change (- 2 nm/half-sarcomere) either while relaxed
or in rigor. Experiment 031589.
FIGURE 3 SC - log(td) relationship at ,. = 40 mM. Comparison of
unmodified fiber in ATP with pPDM-modified fibers ± ATP. Treated
fiber treated with 200 ,uM pPDM for 60 min. For stretches of relatively
long duration, the stiffness remains low as the crossbridges are able to
detach and reattach in positions of lesser strain. However, as the
duration of stretch decreases, the crossbridges can no longer release
the strain before completion of the stretch and the chord stiffness rises.
The fiber after pPDM treatment, whether in rigor or relaxing solution,
gives the same response it gave before modification in the presence of
ATP. Relaxed untreated fiber (O). Relaxed pPDM-treated fiber (0).
Rigor pPDM-treated fiber (X). Experiment 011789.
B_nl al. AT-n. siv Weakly-binding Crossb..d_ es.61
-l w
Barnett et al. ATP-insensitive Weakly-binding Crossbridges 361
crossbridge attachment and detachment rate constants
(Schoenberg, 1985; Schoenberg, 1988a, b), it is clear
that the attachment and detachment rate constants of
the pPDM-modified crossbridge, both in the presence
and absence of ATP, are identical to those of the relaxed
M * ATP crossbridge of normal fibers. In agreement
with previous work (Schoenberg, 1988a), the data of
Fig. 3 suggest crossbridge detachment rate constants on
the order of 5 x 103 S-'.
Site of pPDM reactivity in fibers
In order to examine where pPDM reacts in fibers,
several fibers were treated with '4C-labeled pPDM after
which SDS-PAGE was performed. Some typical results
are shown in Fig. 4. Lanes A and B, respectively, show
SDS-PAGE of both an untreated fiber and a fiber
treated with "4C-pPDM. From the labels on the side of
the picture, it is clear that the control in lane A shows
bands corresponding to nearly all the major muscle
proteins: titin (also referred to as connectin), nebulin,
myosin heavy chain, actin, a-actinin, troponin, and the
myosin light chains. The pattern of the pPDM-treated
fiber in lane B is quite similar except that two new bands
appear: one at the level of myosin dimer (Wang, 1982),
the other somewhat higher. Two other differences be-
tween the control and pPDM-treated gels is that in the
latter the titin bands are significantly diminished and
there is a fair amount of material remaining at the top of
the gel. As lanes E and F, from a Western blot of
duplicates of lanes A and B stained with anti-myosin
IgG/alkaline phosphatase-conjugated anti-IgG show,
both of the new bands that appear after pPDM treat-
ment react with myosin antibody. The lower molecular
weight band likely represents a myosin dimer caused by
crosslinking of two myosin heavy chains and the higher
molecular weight band may well represent a polymer of
several crosslinked myosin heavy chains. Lanes C and D,
autoradiograms of lanes E and F, show that after
"4C-pPDM treatment, most of the radioactivity in the
bands entering the gel is found in the myosin and myosin
dimer bands with a very small amount in the troponin-I,
actin, and at-actinin bands. With further exposure of the
autoradiogram, not only does the lower molecular weight
new band show radioactivity, but the higher molecular
weight one does as well. The material remaining at the
top of the treated gel also shows a fair amount of
radioactivity. This presumably high molecular weight
material at the very top of the gel does not react with
myosin antibody and hence is clearly not heavily
crosslinked myosin. The reduction in intensity of the
normal titin bands in the gel of the pPDM-treated fiber
suggests the possibility it may be crosslinked titin.
A B C D E F
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Nebulin
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a-Actinin
Actin
TnT
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LCl
Tn1
FIGURE 4 2-12% gradient gel of myofibrils from control fibers and
fibers labeled with "4C-pPDM. (A) Control fiber. (B) '4C-pPDM-
treated. (C, D) Scan of a-emission from Western blot of duplicates of
lanesA and B (lanes E and F) (E, F) Western blot analysis of lanesA
and B. Of the three bands that stain with Western blot analysis using
anti-myosin, the lowest molecular weight band is clearly myosin heavy
chain, the next highest is likely a dimer of myosin heavy chain, and the
highest molecular weight band is possibly a higher polymer of
crosslinked myosin heavy chains. The distribution of radioactive
n-emission in lane D, averaged with one other identically-loaded lane
(not illustrated) is: top of gel, 60%; myosin dimer, 12%; myosin, 19%;
a-actinin, trace; actin, trace; troponin I subunit, 8%. The radioactive
material at the top of the gel is believed to be crosslinked titin (see
text).
Source of the increase in resting
stiffness with pPDM-treatment
The effect of pPDM treatment on the titin band of
SDS-PA gels of muscle fibers was unexpected to us, as
was the small linear increase in resting stiffness with
duration of treatment. Even though the increase in
resting stiffness with pPDM treatment is <5% of the
initial rigor stiffness, even after 60 min of treatment, the
increase is real and readily detectable. The conjecture of
Horowitz and Podolsky (1987) that the resting tension at
long sarcomere length is related to titin raises the
possibility that our two unexpected findings are related.
Fig. 5 shows the resting tension of a control fiber compared
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FIGURE 5 Resting tension in control and pPDM-treated fibers. Fig-
ure shows tension response to changing a fiber's resting length from 2.5
,um, where resting tension is zero, to 3.0 p.m. Arrows show resting
tension of a control fiber at 3.0 p.m and the resting tension of the same
fiber at 3.0 p.m after 60 min of treatment with 200 p.m pPDM. As
illustrated, that amount of treatment approximately doubles the
resting tension. Experiment 032690; fiber segment length = 5.3 mm;
fiber diameter, 140 p.m.
origin of resting tension at long sarcomere length, it also
reveals the origin of the small increase in resting chord
stiffness at normal sarcomere length and supports the
calculation of Schoenberg (1988a) that the chord stiff-
ness at normal sarcomere length is largely related to
crossbridges and not the resting tension structures.
Treatment of relaxced fibers with NPM
The use of pPDM as an agent to reduce crossbridge
affinity for actin is based on solution determinations that
pPDM crosslinking of SHi to SH2 results in the stabili-
zation of myosin in an M *ATP-like conformation.
Because there is solution evidence that monofunctional
reagents such as N-phenylmaleimide (NPM) produce
similar effects (Duong and Reisler, 1989), we also
examined the response of skinned psoas fibers to treat-
ment with NPM.
Fig. 6A shows the time course for the change in
relaxed and rigor stiffness after NPM treatment (100
,uM, 5°C) of a relaxed fiber. As with pPDM (Fig. 1), the
rigor stiffness decreases as the length of exposure to
NPM increases and approaches the value of a relaxed
fiber after 40-50 min. In contrast to the pPDM results
there is not a concomitant increase in relaxed stiffness.
The relaxed stiffness is essentially unchanged through-
out the treatment procedure.
Treatment of rigor fibers with NPM
with that of a pPDM-treated fiber. It is clear that treatment
with 200 ,uM pPDM for 60 min approximately doubles
the fiber's resting tension. This finding not only supports
the conjecture of Horowits and Podolsky about the
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It was of interest to determine if having the crossbridges
in rigor during NPM treatment would also protect
against the decrease in rigor stiffness. Fig. 6 shows that
this is partially the case. As with pPDM, the rigor
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FIGURE 6 Time course ofN-phenylmaleimide (NPM) treatment of skinned rabbit psoas fibers. NPM concentration = 100 p.M; temperature, 5°C.
(A) Treatment in resting solution. Rigor stiffness after NPM treatment while relaxed (L). Relaxed stiffness after NPM treatment while relaxed
(0). (B) Treatment in rigor solution. Relaxed stiffness after NPM treatment while in rigor (0). Rigor stiffness after NPM treatment while in rigor
([l). Data points give the average values, with the error bars showing ± SEM. The total number of experiments is 10 for relaxed fiber treatment
(with n = 2 - 10/point), and 6 for rigor fiber treatment (n = 2 - 6/point). When n = 2 the error bar gives the range.
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stiffness after PM treatment in rigor initially increases,
but then, instead of remaining elevated, it decreases so
that it is - 55-65% of the rigor stiffness of an untreated
fiber after 60 min (Fig. 6 B). It is seen then, that while
rigor offers some protection against the action of NPM,
it is not as complete as the protection against pPDM
action. This seems compatible with the idea that NPM is
actually more potent an inhibitor of rigor stiffness than
pPDM, causing a more rapid decrease in rigor stiffness
at 100 p,M concentration than pPDM causes at 200 p,M
(cf. Figs. 1 and 6).
It should also be noted that during NPM treatment of
the rigor fiber, the stiffness of the fiber while relaxed
increases to 5% of the original rigor stiffness within
the first 10-25 min and then remains at that level for the
remainder of the labeling time.
Mechanical properties of
NPM-treated fibers
The mechanical properties of NPM-treated fibers at 165
mM ionic strength was examined using step stretches. As
was the case for pPDM-treated fibers, the stiffness of the
NPM-treated fibers, as seen in Fig. 7, was near zero. To
examine the kinetics of the NPM-treated crossbridges, it
was necessary to lower the ionic strength to 40 mM and
obtain a chord stiffness-duration of stretch relationship.
Fig. 8 shows that, like the pPDM-treated fiber, the
NPM-treated fiber has approximately the same re-
sponse, either in the presence or absence of ATP, as an
untreated relaxed fiber. The detachment rate constants
for NPM-treated fibers, thus, are similar to those of
pPDM-treated fibers and normal relaxed fibers, and are
on the order of i0O to 10' s-.
Site of reactivity of NPM in
muscle fibers
To determine the site of reactivity of NPM in muscle
fibers, a small bundle of muscle fibers was treated with
100 ,uM '4C-NPM for 60 min. SDS-PAGE was then done
on 10-40 ,ug samples of homogenized fiber. LanesA and
B of Fig. 9 show the Coomassie Blue stain of both
untreated (laneA) and NPM-treated (lane B) fibers.
Lanes C andD in Fig. 9 show a 4C scan of lanesA and
B, respectively. Although myosin heavy chain is the most
heavily labeled band, containing 28% of the total counts
in peaks, it is seen that 100 ,uM NPM reacts considerably
more promiscuously than 200 ,uM pPDM, the titin band
also showing heavy labeling (20%), with ot-actinin, actin,
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FIGURE 7 Original records of response to stretch, in rigor and resting
solutions, before and after NPM treatment of a resting skinned rabbit
psoas fiber. Treatment conditions were 100 ,uM NPM for 60 min.
When n = 2 the error bar gives the range. Just as was shown for pPDM
treatment in Fig. 3, NPM treatment causes the modified fiber to
behave as if it were relaxed both in the presence and absence of ATP.
Experiment 031389.
FIGURE 8 S, -log(td) relationship at 40 mM ionic strength. Compar-
ison between unmodified fiber in ATP with NPM-modified fibers ±
ATP. Incubation time = 60 min. The NPM-modified fiber +ATP is
identical in its response to the untreated relaxed fiber. Relaxed
untreated fiber (O). Relaxed NPM-treated fiber (0). Rigor NPM-
treated fiber (X). Experiment 020189.
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FIGURE 9 2-12% gradient gel of myofibrils from control fibers and
fibers treated with '4C-NPM. (A) Control fiber. (B) '4C-NPM-treated.
(C, D) Scan of ,-emission from lanes A and B. The distribution of
radioactive a-emission in lane D due to binding of '4C-NPM to protein
is: top of gel, 14%; titin, 20%; myosin heavy chain, 28%; first small
peak below myosin, 4%; second small peak below myosin, 2%;
a-actinin, 14%; actin, 7%; troponin T subunit, 4%; troponin I subunit,
7%.
and troponin I, showing modest labeling (7-14%). A
small amount of radioactivity ( - 14%) also is seen at the
top of the gel.
Effect of NPM treatment on fiber
resting tension
Fig. 5 revealed that, in our hands, treatment of muscle
fibers with pPDM increases the fiber's resting tension. It
is not clear whether treatment with NPM has a similar
effect, particularly because, as Fig. 9 shows, NPM binds
with titin in the fiber. Fig. 10 reveals that NPM treat-
ment does not increase fiber resting tension. As seen,
treatment of a msucle fiber with 100 ,uM NPM for 60
min, which totally eliminates a fiber's rigor stiffness, has
no effect upon the fiber's resting tension.
DISCUSSION
Chaen et al. (1986) showed that treatment of muscle
fibers with pPDM inhibits their ability to produce active
force. They reasoned that this effect ofpPDM on muscle
Actin-'
TnT-'
Tm-"
LCTI
Tnl~
FIGURE 10 Resting tension in control and NPM-treated fibers. Figure
shows tension response to changing a fiber's resting length from 2.5
,um, where resting tension is zero, to 3.0 ,um. Arrows show resting
tension of a control fiber at 3.0 p.m and the resting tension of the same
fiber at 3.0 ,um after 60 min of treatment with 100 ,uM NPM. As
illustrated, the fiber resting tension is unaffected by the NPM
treatment.
fibers was due to pPDM's ability to reduce the myosin
head's ability to bind to actin, similar to what occurs
when myosin is treated with pPDM in solution. Our
findings support this interpretation. We find that in the
presence or absence of ATP, pPDM-treated cross-
bridges bind to actin with only about the same strength
of binding as normal (untreated) crossbridges bind to
actin in the presence of ATP. This is true both at 165 and
40 mM ionic strength. Thus, pPDM treatment of fibers
indeed reduced crossbridge binding affinity. NPM treat-
ment produces a similar effect.
It is interesting how closely pPDM- or NPM-treated
crossbridges resemble the M * ATP crossbridges of nor-
mal fibers. At 165 mM ionic strength, only a small
fraction of pPDM- or NPM-treated crossbridges are
attached, but at 40 mM ionic strength, sufficient num-
bers are attached to make it possible to compare the
kinetics of the treated crossbridges with those of normal
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M * ATP crossbridges. By generating S,-log(td) plots
(Schoenberg, 1985; Schoenberg, 1988a), we find that,
like M - ATP crossbridges, pPDM-treated and NPM-
treated crossbridges have detachment rate constants on
the order of 104 s-'. The magnitude of the chord stiffness
is also similar for M * ATP and pPDM- or NPM-treated
crossbridges, suggesting that their attachment rate con-
stants are similar as well. Thus, paralleling the situation
for pPDM-treated myosin subfragment-1 in solution,
pPDM or NPM treatment in fibers seems to lock the
crossbridges in an M * ATP-like state.
Besides the above, there are a number of other
parallels between our fiber results and previously pub-
lished results for pPDM and myosin in solution. In
solution, rigor conditions protect against the crosslink-
ing of SH1 and SH2 produced by pPDM (Katoh and
Morita, 1984). Paralleling this, skinned fibers treated
with pPDM while in rigor do not exhibit a reduced rigor
stiffness, even after prolonged treatment (see filled
squares, Fig. 1 B). The close similarity between the fiber
and solution results, combined with our finding that
pPDM and NPM bind to myosin heavy chain in fibers,
makes it likely that the reduction in acto-myosin affinity
is quite possibly due to reaction of the SH1 and SH2
sulfhydryls, just as in solution.
Although the production of weakly-binding cross-
bridges with pPDM or NPM is relatively straightfor-
ward, there are a number of unwanted side effects in
both cases. The major effect of treatment of relaxed
fibers with pPDM or NPM is inhibition of rigor stiffness
and active force production. Having the fibers in rigor
during treatment completely (pPDM) or partially (NPM)
prevents this. One of the complications of treatment
with pPDM or NPM is seen when the fibers are treated
in rigor.
If the only effect of pPDM and NPM treatment is
creation ofweakly-binding crossbridges, and rigor condi-
tions protect against this, then the stiffness of a rigor
fiber treated with either of these compounds should
remain unchanged. Unfortunately, as Figs. 1 B and 6 B
show, treatment with these compounds seems to very
rapidly cause a small, but nonetheless significant, in-
crease in fiber stiffness. We do not, at present know
whether this increase in stiffness is due to an increase in
the stiffness per bridge or an increase in the stiffness of
the structures responsible for the fiber's resting tension.
In either case, if this same effect occurs with treatment
of the relaxed fiber, it makes it difficult to estimate, using
stiffness, the number of crossbridges attached in the
treated fiber in a given condition.
A second complication we saw regarding treatment
with these compounds in the fiber occurred with pPDM
treatment but not with NPM treatment. In our hands,
upon treatment of a relaxed fiber with pPDM, there is a
small, slowly developing, increase in resting stiffness
(see Fig. 1 A). Treatment of a relaxed fiber with NPM
does not increase fiber resting stiffness. Our finding that
pPDM treatment causes an increase in resting tension,
while NPM treatment does not, suggests that the in-
crease in resting stiffness is due to an increase in the
stiffness of the structures responsible for the fiber's
resting tension, rather than to a change in the properties
of the crossbridges.
A final complication with regard to pPDM and NPM
treatment is that the latter compound, under the condi-
tions used in this work, reacts rather promiscuously.
Although the results are entirely consistent with the
hypothesis that NPM exerts its effect in muscle fibers
because it reacts with SH1 or SH2 on the myosin heavy
chain, the promiscuity of the agent makes more work
necessary before this can be proven conclusively.
In summary, following the lead of Chaen, Shimada,
and Sugi (1986), we have developed two similar but
different techniques for creating weakly-binding cross-
bridges in muscle fibers. The weakly-binding cross-
bridges have kinetics extremely similar to those of
normal M * ATP crossbridges. The similarity is much
more marked than in the case of the weakly-binding
crossbridges produced by ATP--y-S binding (Dantzig et
al., 1988). Because the crossbridges produced by treat-
ment with pPDM or NPM are locked in the weakly-
binding configuration regardless of the presence or
absence of nucleotide, it is hoped that these crossbridges
will be useful in providing additional information about
weakly-binding crossbridges, particularly under condi-
tions (ATP plus Ca2+), where M *ATP crossbridges
undergo hydrolysis, release product, and go into a
strongly binding (M * ADP) configuration.
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